A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03760666 · TERMINATED
Trial details
- NCT number
- NCT03760666
- Sponsor
- Clear Creek Bio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2020-12-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.